Loading...

Hesperidin ameliorates bleomycin-induced experimental pulmonary fibrosis via inhibition of TGF-beta1/Smad3/AMPK and IkappaBalpha/NF-kappaB pathways

Bleomycin (BLM) is a chemotherapeutic agent which is associated with Idiopathic pulmonary fibrosis (IPF) due to its chronic administration. Hesperidin, a bioflavonoid has been reported to possess antioxidant, anti-inflammatory, wound healing, and antiapoptotic potential. To evaluate the therapeutic...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:EXCLI J
Main Authors: Zhou, Zheng, Kandhare, Amit D., Kandhare, Anwesha A., Bodhankar, Subhash L.
Format: Artigo
Sprog:Inglês
Udgivet: Leibniz Research Centre for Working Environment and Human Factors 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6785776/
https://ncbi.nlm.nih.gov/pubmed/31611754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17179/excli2019-1094
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!